Jan 09, 2023 / 11:45PM GMT
Natalie Collins - JPMorgan Chase & Co. - Analyst
Hi everyone, and welcome to the 41st Annual J.P. Morgan Healthcare Conference. My name is Natalie Collins, and I'm an associate in the J.P. Morgan healthcare investment banking team.
Just a reminder, we'll follow a 20-minute presentation format, followed by 20 minutes of Q&A. And with that, I'm thrilled to introduce the CEO, Bob Duggan; and co-CEO, Maky Zanganeh, of Summit Therapeutics.
Maky Zanganeh - Summit Therapeutics Inc. - Co-CEO & President
Thank you, Natalie.
(video playing)
Thank you, Shelley. Good afternoon. My name is Maky Zanganeh, the co-CEO at -- and President of Summit Therapeutics. I would like to thank J.P. Morgan team today, especially Mike Gaito, for inviting us to present our company, Summit Therapeutics.
These are forward-looking statements. We take no responsibility in updating any forward-looking statements that we will make in this presentation. I would like to start to give you an update about our Summit company.
Summit became a
Summit Therapeutics Inc at JPMorgan Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot